Evidence map›Paper›PMID 41993340›Full record

ArticlebioRxiv : the preprint server for biology2026

RUNX1-deficiency drives immune-active ER

Sen Han, Dongxi Xiang, Xueqing Chen, Dongyi Zhao, Guyu Qin, Roderick T Bronson, Zhe Li

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sen HanDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Dongxi XiangDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Xueqing ChenDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Dongyi ZhaoDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Guyu QinDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Roderick T BronsonRodent Histopathology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Zhe LiDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.ORCID 0000-0002-3434-0885

Funding

Interplay of mammary luminal cells and environmental factors in establishing p53-deficient premalignant fieldR01CA222560 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI LI, ZHE · 2018 to 2022
$1.9M
DNA damage-related stemness program during BRCA1 breast cancer initiationR01CA295752 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Zhe Li · 2025 to 2026
$1.1M
Development of a clinically relevant mouse model of ER+ breast cancerR21CA256468 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI LI, ZHE · 2021 to 2022
$414k
NCI NIH HHS R01 CA222560NCI NIH HHS R01 CA295752NCI NIH HHS R21 CA256468
6 · The paper itself

Abstract

Recurrent

Indexed as

ER+ breast cancerestrogen receptorinterferon signalingluminal mammary epithelial cellsmacrophagesp53RB1RUNX1STAT1T cells

Identifiers

PMID41993340
PMCPMC13081936

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.